Cargo train services launched from China's deep mountains to Europe
04.28.2020
Cargo train services have been launched from the mountainous area in southwest China’s Sichuan Province to Europe, a significant move to help with the poverty alleviation in the deep mountains of Sichuan.
The text of the news was taken from a English-language source: China.org.cn

At 10 a.m. Tuesday, a train carrying containers of shoes, toys and chemical products departed from the city of Dazhou, marking the inauguration of the services.

The products will be carried to the cities of Moscow and Hamburg before delivered by truck to the countries of Poland, Germany, France, the Netherlands and Italy, according to the Dazhou city government.

The mountainous area in Sichuan was one of China’s most impoverished regions with poor transport facilities in the past. Traditionally, it took about 50 days for local products to be delivered to Europe by road and sea, and the new cargo train services will cut short transport time by over 25 days with only one-fourth of the air delivery costs.

The inauguration of the train services will help local companies explore the global market, and promote the local economy to resume rapid growth following the impact by the novel coronavirus, said an official with the city government.
Analytics on topic
Report
05.01.2020
Report
05.01.2020
Defining the future of freight transport
The aim of the LEVITATE project is to develop a new impact assessment framework to enable policymakers to manage the introduction of connected and automated transport systems, maximise the benefits and utilise the technologies to achieve long-term visions and goals. An essential part of this work seeks to forecast societal level impacts of connected and automated transport systems (CATS). These include impacts on safety, environment, economy and society.
Report
06.20.2019
Report
06.20.2019
The Europe Pharmaceutical Industry in Figures
The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.
Source: European Federation of Pharmaceutical Industries and Associations